Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies

Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-16
DOI
https://doi.org/10.3390/ijms272210274
Primary Topic
Autophagy in Disease and Therapy
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies

Shuyu Zhang, Qionghui Zhan, Xuefang Shen, Ying Li
International Journal of Molecular Sciences
Autophagy in Disease and Therapy
article

Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies

Shuyu Zhang, Qionghui Zhan, Xuefang Shen, Ying Li
article en

Abstract

Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.

International Journal of Molecular SciencesVol. 27(22)
Shanghai Jiao Tong University (CN), Renji Hospital (CN)
National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities
Good health and well-being
Autophagy in Disease and Therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon